Subscribe
istock-931018720-gwengoat
GwenGoat / iStockphoto.com
30 November 2018Big Pharma

EFPIA concerned over SPC waiver amendments

Proposed amendments to the EU’s supplementary protection certificate (SPC) manufacturing waiver risk “further disincentivising investment” in Europe, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
European pharma body criticises SPC waiver vote
6 December 2018   The European Federation of Pharmaceutical Industries and Associations has sharply criticised an opinion on supplementary protection certificate proposals that was issued by a European Parliament committee.
Big Pharma
EU committee approves SPC waiver
24 January 2019   The Legal Committee of the European Parliament has voted in favour of the proposed supplementary protection certificate waiver.
Generics
European Council agrees on SPC manufacturing waiver
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Big Pharma
European pharma body criticises SPC waiver vote
6 December 2018   The European Federation of Pharmaceutical Industries and Associations has sharply criticised an opinion on supplementary protection certificate proposals that was issued by a European Parliament committee.
Big Pharma
EU committee approves SPC waiver
24 January 2019   The Legal Committee of the European Parliament has voted in favour of the proposed supplementary protection certificate waiver.
Generics
European Council agrees on SPC manufacturing waiver
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.

More on this story

Big Pharma
European pharma body criticises SPC waiver vote
6 December 2018   The European Federation of Pharmaceutical Industries and Associations has sharply criticised an opinion on supplementary protection certificate proposals that was issued by a European Parliament committee.
Big Pharma
EU committee approves SPC waiver
24 January 2019   The Legal Committee of the European Parliament has voted in favour of the proposed supplementary protection certificate waiver.
Generics
European Council agrees on SPC manufacturing waiver
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York